Stock Yards Bank & Trust Co. Decreases Position in Xylem Inc. $XYL

Stock Yards Bank & Trust Co. cut its stake in shares of Xylem Inc. (NYSE:XYL) by 23.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,333 shares of the industrial products company’s stock after selling 1,024 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Xylem were worth $431,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in XYL. Price T Rowe Associates Inc. MD raised its position in Xylem by 689.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock valued at $443,074,000 after purchasing an additional 3,239,203 shares during the period. Nuveen LLC purchased a new stake in Xylem during the first quarter valued at approximately $99,726,000. OVERSEA CHINESE BANKING Corp Ltd raised its position in Xylem by 390.5% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company’s stock valued at $122,009,000 after purchasing an additional 813,100 shares during the period. Vaughan Nelson Investment Management L.P. purchased a new stake in Xylem during the first quarter valued at approximately $89,828,000. Finally, Swedbank AB raised its position in Xylem by 13.9% during the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock valued at $564,906,000 after purchasing an additional 531,890 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Stock Up 0.7%

Shares of NYSE:XYL opened at $149.99 on Friday. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $150.98. The stock has a market cap of $36.51 billion, a P/E ratio of 38.96, a price-to-earnings-growth ratio of 2.59 and a beta of 1.13. The business’s 50 day moving average is $141.96 and its 200 day moving average is $129.48. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The company had revenue of $2.30 billion for the quarter, compared to analysts’ expectations of $2.20 billion. During the same quarter in the prior year, the firm earned $1.09 earnings per share. Xylem’s revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts predict that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were paid a $0.40 dividend. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem’s dividend payout ratio is 41.56%.

Analyst Ratings Changes

Several brokerages have recently weighed in on XYL. Barclays began coverage on Xylem in a report on Friday, September 19th. They issued an “overweight” rating and a $165.00 price target on the stock. Citigroup reiterated a “buy” rating and issued a $152.00 price target (up from $137.00) on shares of Xylem in a report on Monday, July 14th. UBS Group increased their price target on Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a report on Tuesday, August 5th. Weiss Ratings reiterated a “buy (b)” rating on shares of Xylem in a report on Saturday, September 27th. Finally, Stifel Nicolaus increased their price target on Xylem from $162.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, August 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $152.33.

Insider Transactions at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.27% of the company’s stock.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.